Price Alert

NewAmsterdam Pharma N.V. (NAMSW)

NASDAQ: NAMSW · Real-Time Price · USD

14.48

-0.77 (-5.05%)

At close: Sep 11, 2025, 3:47 PM

NewAmsterdam Pharma Revenue

NewAmsterdam Pharma reported an annual revenue of $45.56M, reflecting a undefined% growth. For the quarter ending June 30, 2025, NewAmsterdam Pharma generated $19.14M in revenue.

Revenue (ttm)

n/a

Revenue Growth

n/a

Price / Sales Ratio

n/a

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.63B

Revenue Chart

History

Fiscal Year End	Revenue	% Change
Dec 31, 2024	45.56M	+257.00%
Dec 31, 2023	12.76M	-86.69%
Dec 31, 2022	95.91M	+Infinity%
Dec 31, 2021	0	n/a
Dec 31, 2020	0	n/a

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company	Revenue
NewAmsterdam Pharma Company	45.56M

Revenue Rankings